
Kuni Foundation awards $13.4 million to advance IDD inclusion and cancer research across the Pacific Northwest
By Kuni Foundation | | Cancer Research, Grants, Intellectual & Developmental Disabilities, PhilanthropyFunding deepens ongoing commitment to accelerate inclusion for people with intellectual and developmental disabilities and world-class cancer studies in…

Kuni Foundation Awards $11.3 million to Washington and Oregon Nonprofits
By Robyn Shuey | | Advocacy, Cancer Research, Grants, Intellectual & Developmental Disabilities, PhilanthropyFunding accelerates inclusion for people with intellectual and developmental disabilities and revolutionary cancer research.From a documentary film on Autism…

Kuni Foundation Awards $2.5 million to Advance IDD Housing Options and Catalytic Cancer Research
By Robyn Shuey | | Cancer Research, Community, Grants, Intellectual & Developmental Disabilities, PhilanthropyFunded projects include renovations to assist in aging in place for residents with IDD, the use of artificial intelligence…

Kuni Foundation Awards 36 Imagination Grants to Advance Innovation and Inclusion in Oregon and Washington
By Robyn Shuey | | Cancer Research, Community, equity, Grants, Intellectual & Developmental Disabilities, PhilanthropyFunded projects include immunotherapeutic hydrogel for pancreatic cancer treatment, advancing precision radiotherapy for tumors, program expansion for neurodiv…

Kuni Foundation Welcomes Robyn Shuey as Director of Grants and Programs
By Angela Hult | | Advocacy, Cancer Research, Community, Grants, Intellectual & Developmental Disabilities, PhilanthropyRobyn Shuey is joining the Kuni Foundation as Director of Grants and Programs, a new role that reflects the…

Kuni Foundation Awards $13.2 Million to Oregon and Washington Nonprofits
By Angela Hult | | Advocacy, Cancer Research, Community, equity, Grants, Intellectual & Developmental Disabilities, STEMGrants Support Research Dismantling Disparities in Cancer Detection and Treatment for BIPOC Communities; Innovative Housing Solutions for People Experiencing…

PDX Pharmaceuticals Secures Additional Investment from the Kuni Foundation to Advance New Cancer-Fighting Precision Therapies
By Kuni Foundation | | Cancer ResearchPortland, Oregon -- PDX Pharmaceuticals, a privately held company developing first-in-class nanotechnology-based therapies for treating cancer, received a seco…











